K
KLOTHO NEUROSCIENCES, INC.
NASDAQ: KLTO (Klotho Neurosciences, Inc.)
最近更新时间: 6小时之前0.221
0.00 (1.33%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Klotho Neurosciences, Inc. | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.7 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 0.0 |
| 相对估值 | NA |
| 财务健康 | -5.0 |
| 宏观环境 | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -1.02 |
|
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 50.23% |
| 机构持股比例 | 2.60% |
投资组合